Support for Bereaved Cancer Caregivers
This study is for family and friends who have recently lost a loved one to cancer and are experiencing grief. It's testing a new approach called Nature-based healing meditation (NBHM) intervention. This intervention involves listening to 6 nature-based meditation audio modules online to help with grief recovery. The study wants to see if this intervention is practical and acceptable to caregivers, and if it helps with attention, grief, and overall quality of life (including feelings of depression and anxiety). You can join if you are 18 or older, can speak English, have a phone, and can hear normal conversations. The study is currently unclear on its recruitment status and plans to enroll 70 participants.
- Study design
- This is an interventional study that plans to enroll 70 participants. It is testing a nature-based healing meditation intervention.
- What's involved
- You would participate in a 6-week program involving nature-based healing meditation audio modules. Your attention, grief, and quality of life will be assessed from the start to the end of the 12-week intervention period.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your progress will be measured from the start of the study until the end of the intervention at 12 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Support for Bereaved Cancer Caregivers
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility of Intervention MeasureFrom baseline to the end of intervention at 12 weeks
The 4-item Feasibility of Intervention Measure was developed for evaluating the success of feasibility, demonstrate encouraging psychometric properties. The items that are scored on a scale of 0 to 4 where 0 indicates "completely disagree," and 4 indicates "completely agree". Thus, the range for each scale extends from 0 - 16 with higher scores indicating higher feasibility and acceptability.
- Acceptability of Intervention MeasureFrom baseline to the end of intervention at 12 weeks
The 4-item Acceptability of Intervention Measure was developed for evaluating the success of acceptability, demonstrate encouraging psychometric properties. The items that are scored on a scale of 0 to 4 where 0 indicates "completely disagree," and 4 indicates "completely agree". Thus, the range for each scale extends from 0 - 16 with higher scores indicating higher feasibility and acceptability.
- Attention Function IndexFrom baseline to the end of intervention at 12 weeks
Directed attention will be assessed with the Attention Function Index, a 16-item self-rating scale that measures perceived effectiveness in daily tasks that require cognitive function. Items are scored on an 11-point Likert scale ranging from 0, indicating "not at all," to 10, indicating "extremely well or a great deal." Higher scores indicate better cognitive functioning.
- Prolonged Grief 13-RevisedFrom baseline to the end of intervention at 12 weeks
Grief (Bereavement) will be measured with the Prolonged Grief 13-Revised prolonged grief scale, Ongoing testing demonstrates that the measure is consistently reliable and a valid instrument for classifying less adaptive grief responses. Thirteen items to assess symptoms of prolonged grief disorder. Ten items are scored on a Likert-style scale from 1, "not at all," to 5 "overwhelmingly" to indicate how often that item describes how they are feeling. Three of the items assess whether the respondent had lost a significant other, how long ago the death occurred, and impairment associated with symptoms. Scores of 30 or greater on the symptom items indicate prolonged grief disorder (PGD), and were associated with poorer emotional and mental health as well as work and social adjustment difficulties.
- PROMIS-29: Quality of lifeFrom baseline to the end of intervention at 12 weeks
The PROMIS profile instruments are a collection of profile short forms, where each form contains items from 1 of 7 primary PROMIS domains (emotional, social, and physical function, pain interference, fatigue, sleep disturbance, health satisfaction). PROMIS tools were developed to create psychometrically robust fixed-length short forms that can be used across trials and clinical conditions. The PROMIS-29 assesses each domain with 4 questions each. Items are on a 5-point Likert scale that ranges from 0 to 4.
- Acceptability and Feasibility TrackingFrom baseline to the end of intervention at 12 weeks
participant numbers referred vs numbers eligible; numbers eligible vs. number consented; numbers consented vs. number completed; number of weeks using the intervention.